Tag: safety

Home / safety
Post

Health Canada assessing NDMA in ranitidine

Health Canada is informing Canadians that it is aware that the impurity N-nitrosodimethylamine (NDMA) has been detected in some ranitidine drugs. Health Canada is closely assessing the issue in collaboration with other regulators internationally, including the U.S. Food and Drug Administration and the European Medicines Agency. The Department will take action as needed, and will keep...

Post

Opioid Use

Health Canada strengthens safety information for all opioid drugs Health Canada held a Scientific Advisory Panel on Opioid Use and Contraindications, to consider whether the current contraindications for opioid use are sufficient, or whether labelling updates and other actions may be needed to reduce risks to Canadians. After thoroughly assessing the Panel’s recommendations, Health Canada is...